Medical Care
Global Personalized Cancer Medicine Market Insights, Forecast to 2030
- Mar 07, 25
- ID: 1668
- Pages: 109
- Figures: 135
- Views: 3
Personalized medicine is at an early stage of development. Scientists found that some cancer cells have particular proteins in the cell and others don’t. Sometimes, cancer cells have far more of a particular protein than healthy cells. Genetic testing of cancer cells and normal cells helps doctors customize treatment to individual patient needs. Personalized treatments may cause fewer side effects than standard options. Some people are already benefiting from this approach.
Market Analysis and Insights: Global Personalized Cancer Medicine Market
The global Personalized Cancer Medicine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Personalized Cancer Medicine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Personalized Cancer Medicine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Personalized Cancer Medicine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key companies of Personalized Cancer Medicine include Abbott, Merck, Novartis, Amgen, Celgene, Bayer, Roche, Astellas and Astrazeneca, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Personalized Cancer Medicine is widely used in various fields, such as Breast Cancer, Lung Cancer, Chronic Myeloid Leukaemia and Bowel Cancer, etc. Breast Cancer provides greatest supports to the Personalized Cancer Medicine industry development. In 2023, global % revenue of Personalized Cancer Medicine went into Breast Cancer filed and the proportion will reach to % in 2030.
Report Covers:
This report presents an overview of global market for Personalized Cancer Medicine market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Personalized Cancer Medicine, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Personalized Cancer Medicine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Personalized Cancer Medicine revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Personalized Cancer Medicine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Personalized Cancer Medicine revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Abbott
Merck
Novartis
Amgen
Celgene
Bayer
Roche
Astellas
Astrazeneca
Johnson & Johnson
Agilent
Takeda
Segment by Type
Monoclonal Antibodies
Personalized Cancer Vaccines
Other
Segment by Application
Breast Cancer
Lung Cancer
Chronic Myeloid Leukaemia
Bowel Cancer
Other Cancer
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Personalized Cancer Medicine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Personalized Cancer Medicine companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Personalized Cancer Medicine revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Market Analysis and Insights: Global Personalized Cancer Medicine Market
The global Personalized Cancer Medicine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Personalized Cancer Medicine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Personalized Cancer Medicine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Personalized Cancer Medicine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key companies of Personalized Cancer Medicine include Abbott, Merck, Novartis, Amgen, Celgene, Bayer, Roche, Astellas and Astrazeneca, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Personalized Cancer Medicine is widely used in various fields, such as Breast Cancer, Lung Cancer, Chronic Myeloid Leukaemia and Bowel Cancer, etc. Breast Cancer provides greatest supports to the Personalized Cancer Medicine industry development. In 2023, global % revenue of Personalized Cancer Medicine went into Breast Cancer filed and the proportion will reach to % in 2030.
Report Covers:
This report presents an overview of global market for Personalized Cancer Medicine market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Personalized Cancer Medicine, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Personalized Cancer Medicine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Personalized Cancer Medicine revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Personalized Cancer Medicine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Personalized Cancer Medicine revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Abbott
Merck
Novartis
Amgen
Celgene
Bayer
Roche
Astellas
Astrazeneca
Johnson & Johnson
Agilent
Takeda
Segment by Type
Monoclonal Antibodies
Personalized Cancer Vaccines
Other
Segment by Application
Breast Cancer
Lung Cancer
Chronic Myeloid Leukaemia
Bowel Cancer
Other Cancer
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Personalized Cancer Medicine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Personalized Cancer Medicine companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Personalized Cancer Medicine revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Personalized Cancer Medicine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Monoclonal Antibodies
1.2.3 Personalized Cancer Vaccines
1.2.4 Other
1.3 Market by Application
1.3.1 Global Personalized Cancer Medicine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Breast Cancer
1.3.3 Lung Cancer
1.3.4 Chronic Myeloid Leukaemia
1.3.5 Bowel Cancer
1.3.6 Other Cancer
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Personalized Cancer Medicine Market Perspective (2019-2030)
2.2 Global Personalized Cancer Medicine Growth Trends by Region
2.2.1 Personalized Cancer Medicine Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Personalized Cancer Medicine Historic Market Size by Region (2019-2024)
2.2.3 Personalized Cancer Medicine Forecasted Market Size by Region (2025-2030)
2.3 Personalized Cancer Medicine Market Dynamics
2.3.1 Personalized Cancer Medicine Industry Trends
2.3.2 Personalized Cancer Medicine Market Drivers
2.3.3 Personalized Cancer Medicine Market Challenges
2.3.4 Personalized Cancer Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Personalized Cancer Medicine by Players
3.1.1 Global Personalized Cancer Medicine Revenue by Players (2019-2024)
3.1.2 Global Personalized Cancer Medicine Revenue Market Share by Players (2019-2024)
3.2 Global Personalized Cancer Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Personalized Cancer Medicine, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Personalized Cancer Medicine Market Concentration Ratio
3.4.1 Global Personalized Cancer Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Personalized Cancer Medicine Revenue in 2023
3.5 Global Key Players of Personalized Cancer Medicine Head office and Area Served
3.6 Global Key Players of Personalized Cancer Medicine, Product and Application
3.7 Global Key Players of Personalized Cancer Medicine, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Personalized Cancer Medicine Breakdown Data by Type
4.1 Global Personalized Cancer Medicine Historic Market Size by Type (2019-2024)
4.2 Global Personalized Cancer Medicine Forecasted Market Size by Type (2025-2030)
5 Personalized Cancer Medicine Breakdown Data by Application
5.1 Global Personalized Cancer Medicine Historic Market Size by Application (2019-2024)
5.2 Global Personalized Cancer Medicine Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Personalized Cancer Medicine Market Size (2019-2030)
6.2 North America Personalized Cancer Medicine Market Size by Type
6.2.1 North America Personalized Cancer Medicine Market Size by Type (2019-2024)
6.2.2 North America Personalized Cancer Medicine Market Size by Type (2025-2030)
6.2.3 North America Personalized Cancer Medicine Market Share by Type (2019-2030)
6.3 North America Personalized Cancer Medicine Market Size by Application
6.3.1 North America Personalized Cancer Medicine Market Size by Application (2019-2024)
6.3.2 North America Personalized Cancer Medicine Market Size by Application (2025-2030)
6.3.3 North America Personalized Cancer Medicine Market Share by Application (2019-2030)
6.4 North America Personalized Cancer Medicine Market Size by Country
6.4.1 North America Personalized Cancer Medicine Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Personalized Cancer Medicine Market Size by Country (2019-2024)
6.4.3 North America Personalized Cancer Medicine Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Personalized Cancer Medicine Market Size (2019-2030)
7.2 Europe Personalized Cancer Medicine Market Size by Type
7.2.1 Europe Personalized Cancer Medicine Market Size by Type (2019-2024)
7.2.2 Europe Personalized Cancer Medicine Market Size by Type (2025-2030)
7.2.3 Europe Personalized Cancer Medicine Market Share by Type (2019-2030)
7.3 Europe Personalized Cancer Medicine Market Size by Application
7.3.1 Europe Personalized Cancer Medicine Market Size by Application (2019-2024)
7.3.2 Europe Personalized Cancer Medicine Market Size by Application (2025-2030)
7.3.3 Europe Personalized Cancer Medicine Market Share by Application (2019-2030)
7.4 Europe Personalized Cancer Medicine Market Size by Country
7.4.1 Europe Personalized Cancer Medicine Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Personalized Cancer Medicine Market Size by Country (2019-2024)
7.4.3 Europe Personalized Cancer Medicine Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Personalized Cancer Medicine Market Size (2019-2030)
8.2 China Personalized Cancer Medicine Market Size by Type
8.2.1 China Personalized Cancer Medicine Market Size by Type (2019-2024)
8.2.2 China Personalized Cancer Medicine Market Size by Type (2025-2030)
8.2.3 China Personalized Cancer Medicine Market Share by Type (2019-2030)
8.3 China Personalized Cancer Medicine Market Size by Application
8.3.1 China Personalized Cancer Medicine Market Size by Application (2019-2024)
8.3.2 China Personalized Cancer Medicine Market Size by Application (2025-2030)
8.3.3 China Personalized Cancer Medicine Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Personalized Cancer Medicine Market Size (2019-2030)
9.2 Asia Personalized Cancer Medicine Market Size by Type
9.2.1 Asia Personalized Cancer Medicine Market Size by Type (2019-2024)
9.2.2 Asia Personalized Cancer Medicine Market Size by Type (2025-2030)
9.2.3 Asia Personalized Cancer Medicine Market Share by Type (2019-2030)
9.3 Asia Personalized Cancer Medicine Market Size by Application
9.3.1 Asia Personalized Cancer Medicine Market Size by Application (2019-2024)
9.3.2 Asia Personalized Cancer Medicine Market Size by Application (2025-2030)
9.3.3 Asia Personalized Cancer Medicine Market Share by Application (2019-2030)
9.4 Asia Personalized Cancer Medicine Market Size by Region
9.4.1 Asia Personalized Cancer Medicine Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Personalized Cancer Medicine Market Size by Region (2019-2024)
9.4.3 Asia Personalized Cancer Medicine Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Personalized Cancer Medicine Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Personalized Cancer Medicine Market Size by Type
10.2.1 Middle East, Africa, and Latin America Personalized Cancer Medicine Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Personalized Cancer Medicine Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Personalized Cancer Medicine Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Personalized Cancer Medicine Market Size by Application
10.3.1 Middle East, Africa, and Latin America Personalized Cancer Medicine Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Personalized Cancer Medicine Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Personalized Cancer Medicine Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Personalized Cancer Medicine Market Size by Country
10.4.1 Middle East, Africa, and Latin America Personalized Cancer Medicine Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Personalized Cancer Medicine Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Personalized Cancer Medicine Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Personalized Cancer Medicine Introduction
11.1.4 Abbott Revenue in Personalized Cancer Medicine Business (2019-2024)
11.1.5 Abbott Recent Developments
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Personalized Cancer Medicine Introduction
11.2.4 Merck Revenue in Personalized Cancer Medicine Business (2019-2024)
11.2.5 Merck Recent Developments
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Personalized Cancer Medicine Introduction
11.3.4 Novartis Revenue in Personalized Cancer Medicine Business (2019-2024)
11.3.5 Novartis Recent Developments
11.4 Amgen
11.4.1 Amgen Company Details
11.4.2 Amgen Business Overview
11.4.3 Amgen Personalized Cancer Medicine Introduction
11.4.4 Amgen Revenue in Personalized Cancer Medicine Business (2019-2024)
11.4.5 Amgen Recent Developments
11.5 Celgene
11.5.1 Celgene Company Details
11.5.2 Celgene Business Overview
11.5.3 Celgene Personalized Cancer Medicine Introduction
11.5.4 Celgene Revenue in Personalized Cancer Medicine Business (2019-2024)
11.5.5 Celgene Recent Developments
11.6 Bayer
11.6.1 Bayer Company Details
11.6.2 Bayer Business Overview
11.6.3 Bayer Personalized Cancer Medicine Introduction
11.6.4 Bayer Revenue in Personalized Cancer Medicine Business (2019-2024)
11.6.5 Bayer Recent Developments
11.7 Roche
11.7.1 Roche Company Details
11.7.2 Roche Business Overview
11.7.3 Roche Personalized Cancer Medicine Introduction
11.7.4 Roche Revenue in Personalized Cancer Medicine Business (2019-2024)
11.7.5 Roche Recent Developments
11.8 Astellas
11.8.1 Astellas Company Details
11.8.2 Astellas Business Overview
11.8.3 Astellas Personalized Cancer Medicine Introduction
11.8.4 Astellas Revenue in Personalized Cancer Medicine Business (2019-2024)
11.8.5 Astellas Recent Developments
11.9 Astrazeneca
11.9.1 Astrazeneca Company Details
11.9.2 Astrazeneca Business Overview
11.9.3 Astrazeneca Personalized Cancer Medicine Introduction
11.9.4 Astrazeneca Revenue in Personalized Cancer Medicine Business (2019-2024)
11.9.5 Astrazeneca Recent Developments
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Company Details
11.10.2 Johnson & Johnson Business Overview
11.10.3 Johnson & Johnson Personalized Cancer Medicine Introduction
11.10.4 Johnson & Johnson Revenue in Personalized Cancer Medicine Business (2019-2024)
11.10.5 Johnson & Johnson Recent Developments
11.11 Agilent
11.11.1 Agilent Company Details
11.11.2 Agilent Business Overview
11.11.3 Agilent Personalized Cancer Medicine Introduction
11.11.4 Agilent Revenue in Personalized Cancer Medicine Business (2019-2024)
11.11.5 Agilent Recent Developments
11.12 Takeda
11.12.1 Takeda Company Details
11.12.2 Takeda Business Overview
11.12.3 Takeda Personalized Cancer Medicine Introduction
11.12.4 Takeda Revenue in Personalized Cancer Medicine Business (2019-2024)
11.12.5 Takeda Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Personalized Cancer Medicine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Monoclonal Antibodies
1.2.3 Personalized Cancer Vaccines
1.2.4 Other
1.3 Market by Application
1.3.1 Global Personalized Cancer Medicine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Breast Cancer
1.3.3 Lung Cancer
1.3.4 Chronic Myeloid Leukaemia
1.3.5 Bowel Cancer
1.3.6 Other Cancer
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Personalized Cancer Medicine Market Perspective (2019-2030)
2.2 Global Personalized Cancer Medicine Growth Trends by Region
2.2.1 Personalized Cancer Medicine Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Personalized Cancer Medicine Historic Market Size by Region (2019-2024)
2.2.3 Personalized Cancer Medicine Forecasted Market Size by Region (2025-2030)
2.3 Personalized Cancer Medicine Market Dynamics
2.3.1 Personalized Cancer Medicine Industry Trends
2.3.2 Personalized Cancer Medicine Market Drivers
2.3.3 Personalized Cancer Medicine Market Challenges
2.3.4 Personalized Cancer Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Personalized Cancer Medicine by Players
3.1.1 Global Personalized Cancer Medicine Revenue by Players (2019-2024)
3.1.2 Global Personalized Cancer Medicine Revenue Market Share by Players (2019-2024)
3.2 Global Personalized Cancer Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Personalized Cancer Medicine, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Personalized Cancer Medicine Market Concentration Ratio
3.4.1 Global Personalized Cancer Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Personalized Cancer Medicine Revenue in 2023
3.5 Global Key Players of Personalized Cancer Medicine Head office and Area Served
3.6 Global Key Players of Personalized Cancer Medicine, Product and Application
3.7 Global Key Players of Personalized Cancer Medicine, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Personalized Cancer Medicine Breakdown Data by Type
4.1 Global Personalized Cancer Medicine Historic Market Size by Type (2019-2024)
4.2 Global Personalized Cancer Medicine Forecasted Market Size by Type (2025-2030)
5 Personalized Cancer Medicine Breakdown Data by Application
5.1 Global Personalized Cancer Medicine Historic Market Size by Application (2019-2024)
5.2 Global Personalized Cancer Medicine Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Personalized Cancer Medicine Market Size (2019-2030)
6.2 North America Personalized Cancer Medicine Market Size by Type
6.2.1 North America Personalized Cancer Medicine Market Size by Type (2019-2024)
6.2.2 North America Personalized Cancer Medicine Market Size by Type (2025-2030)
6.2.3 North America Personalized Cancer Medicine Market Share by Type (2019-2030)
6.3 North America Personalized Cancer Medicine Market Size by Application
6.3.1 North America Personalized Cancer Medicine Market Size by Application (2019-2024)
6.3.2 North America Personalized Cancer Medicine Market Size by Application (2025-2030)
6.3.3 North America Personalized Cancer Medicine Market Share by Application (2019-2030)
6.4 North America Personalized Cancer Medicine Market Size by Country
6.4.1 North America Personalized Cancer Medicine Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Personalized Cancer Medicine Market Size by Country (2019-2024)
6.4.3 North America Personalized Cancer Medicine Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Personalized Cancer Medicine Market Size (2019-2030)
7.2 Europe Personalized Cancer Medicine Market Size by Type
7.2.1 Europe Personalized Cancer Medicine Market Size by Type (2019-2024)
7.2.2 Europe Personalized Cancer Medicine Market Size by Type (2025-2030)
7.2.3 Europe Personalized Cancer Medicine Market Share by Type (2019-2030)
7.3 Europe Personalized Cancer Medicine Market Size by Application
7.3.1 Europe Personalized Cancer Medicine Market Size by Application (2019-2024)
7.3.2 Europe Personalized Cancer Medicine Market Size by Application (2025-2030)
7.3.3 Europe Personalized Cancer Medicine Market Share by Application (2019-2030)
7.4 Europe Personalized Cancer Medicine Market Size by Country
7.4.1 Europe Personalized Cancer Medicine Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Personalized Cancer Medicine Market Size by Country (2019-2024)
7.4.3 Europe Personalized Cancer Medicine Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Personalized Cancer Medicine Market Size (2019-2030)
8.2 China Personalized Cancer Medicine Market Size by Type
8.2.1 China Personalized Cancer Medicine Market Size by Type (2019-2024)
8.2.2 China Personalized Cancer Medicine Market Size by Type (2025-2030)
8.2.3 China Personalized Cancer Medicine Market Share by Type (2019-2030)
8.3 China Personalized Cancer Medicine Market Size by Application
8.3.1 China Personalized Cancer Medicine Market Size by Application (2019-2024)
8.3.2 China Personalized Cancer Medicine Market Size by Application (2025-2030)
8.3.3 China Personalized Cancer Medicine Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Personalized Cancer Medicine Market Size (2019-2030)
9.2 Asia Personalized Cancer Medicine Market Size by Type
9.2.1 Asia Personalized Cancer Medicine Market Size by Type (2019-2024)
9.2.2 Asia Personalized Cancer Medicine Market Size by Type (2025-2030)
9.2.3 Asia Personalized Cancer Medicine Market Share by Type (2019-2030)
9.3 Asia Personalized Cancer Medicine Market Size by Application
9.3.1 Asia Personalized Cancer Medicine Market Size by Application (2019-2024)
9.3.2 Asia Personalized Cancer Medicine Market Size by Application (2025-2030)
9.3.3 Asia Personalized Cancer Medicine Market Share by Application (2019-2030)
9.4 Asia Personalized Cancer Medicine Market Size by Region
9.4.1 Asia Personalized Cancer Medicine Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Personalized Cancer Medicine Market Size by Region (2019-2024)
9.4.3 Asia Personalized Cancer Medicine Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Personalized Cancer Medicine Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Personalized Cancer Medicine Market Size by Type
10.2.1 Middle East, Africa, and Latin America Personalized Cancer Medicine Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Personalized Cancer Medicine Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Personalized Cancer Medicine Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Personalized Cancer Medicine Market Size by Application
10.3.1 Middle East, Africa, and Latin America Personalized Cancer Medicine Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Personalized Cancer Medicine Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Personalized Cancer Medicine Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Personalized Cancer Medicine Market Size by Country
10.4.1 Middle East, Africa, and Latin America Personalized Cancer Medicine Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Personalized Cancer Medicine Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Personalized Cancer Medicine Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Personalized Cancer Medicine Introduction
11.1.4 Abbott Revenue in Personalized Cancer Medicine Business (2019-2024)
11.1.5 Abbott Recent Developments
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Personalized Cancer Medicine Introduction
11.2.4 Merck Revenue in Personalized Cancer Medicine Business (2019-2024)
11.2.5 Merck Recent Developments
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Personalized Cancer Medicine Introduction
11.3.4 Novartis Revenue in Personalized Cancer Medicine Business (2019-2024)
11.3.5 Novartis Recent Developments
11.4 Amgen
11.4.1 Amgen Company Details
11.4.2 Amgen Business Overview
11.4.3 Amgen Personalized Cancer Medicine Introduction
11.4.4 Amgen Revenue in Personalized Cancer Medicine Business (2019-2024)
11.4.5 Amgen Recent Developments
11.5 Celgene
11.5.1 Celgene Company Details
11.5.2 Celgene Business Overview
11.5.3 Celgene Personalized Cancer Medicine Introduction
11.5.4 Celgene Revenue in Personalized Cancer Medicine Business (2019-2024)
11.5.5 Celgene Recent Developments
11.6 Bayer
11.6.1 Bayer Company Details
11.6.2 Bayer Business Overview
11.6.3 Bayer Personalized Cancer Medicine Introduction
11.6.4 Bayer Revenue in Personalized Cancer Medicine Business (2019-2024)
11.6.5 Bayer Recent Developments
11.7 Roche
11.7.1 Roche Company Details
11.7.2 Roche Business Overview
11.7.3 Roche Personalized Cancer Medicine Introduction
11.7.4 Roche Revenue in Personalized Cancer Medicine Business (2019-2024)
11.7.5 Roche Recent Developments
11.8 Astellas
11.8.1 Astellas Company Details
11.8.2 Astellas Business Overview
11.8.3 Astellas Personalized Cancer Medicine Introduction
11.8.4 Astellas Revenue in Personalized Cancer Medicine Business (2019-2024)
11.8.5 Astellas Recent Developments
11.9 Astrazeneca
11.9.1 Astrazeneca Company Details
11.9.2 Astrazeneca Business Overview
11.9.3 Astrazeneca Personalized Cancer Medicine Introduction
11.9.4 Astrazeneca Revenue in Personalized Cancer Medicine Business (2019-2024)
11.9.5 Astrazeneca Recent Developments
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Company Details
11.10.2 Johnson & Johnson Business Overview
11.10.3 Johnson & Johnson Personalized Cancer Medicine Introduction
11.10.4 Johnson & Johnson Revenue in Personalized Cancer Medicine Business (2019-2024)
11.10.5 Johnson & Johnson Recent Developments
11.11 Agilent
11.11.1 Agilent Company Details
11.11.2 Agilent Business Overview
11.11.3 Agilent Personalized Cancer Medicine Introduction
11.11.4 Agilent Revenue in Personalized Cancer Medicine Business (2019-2024)
11.11.5 Agilent Recent Developments
11.12 Takeda
11.12.1 Takeda Company Details
11.12.2 Takeda Business Overview
11.12.3 Takeda Personalized Cancer Medicine Introduction
11.12.4 Takeda Revenue in Personalized Cancer Medicine Business (2019-2024)
11.12.5 Takeda Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Personalized Cancer Medicine Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Key Players of Monoclonal Antibodies
Table 3. Key Players of Personalized Cancer Vaccines
Table 4. Key Players of Other
Table 5. Global Personalized Cancer Medicine Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 6. Global Personalized Cancer Medicine Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Personalized Cancer Medicine Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Personalized Cancer Medicine Market Share by Region (2019-2024)
Table 9. Global Personalized Cancer Medicine Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Personalized Cancer Medicine Market Share by Region (2025-2030)
Table 11. Personalized Cancer Medicine Market Trends
Table 12. Personalized Cancer Medicine Market Drivers
Table 13. Personalized Cancer Medicine Market Challenges
Table 14. Personalized Cancer Medicine Market Restraints
Table 15. Global Personalized Cancer Medicine Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Personalized Cancer Medicine Revenue Share by Players (2019-2024)
Table 17. Global Top Personalized Cancer Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Cancer Medicine as of 2023)
Table 18. Global Personalized Cancer Medicine Industry Ranking 2022 VS 2023 VS 2024
Table 19. Global 5 Largest Players Market Share by Personalized Cancer Medicine Revenue (CR5 and HHI) & (2019-2024)
Table 20. Global Key Players of Personalized Cancer Medicine, Headquarters and Area Served
Table 21. Global Key Players of Personalized Cancer Medicine, Product and Application
Table 22. Global Key Players of Personalized Cancer Medicine, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Personalized Cancer Medicine Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Personalized Cancer Medicine Revenue Market Share by Type (2019-2024)
Table 26. Global Personalized Cancer Medicine Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Personalized Cancer Medicine Revenue Market Share by Type (2025-2030)
Table 28. Global Personalized Cancer Medicine Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Personalized Cancer Medicine Revenue Share by Application (2019-2024)
Table 30. Global Personalized Cancer Medicine Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Personalized Cancer Medicine Revenue Share by Application (2025-2030)
Table 32. North America Personalized Cancer Medicine Market Size by Type (2019-2024) & (US$ Million)
Table 33. North America Personalized Cancer Medicine Market Size by Type (2025-2030) & (US$ Million)
Table 34. North America Personalized Cancer Medicine Market Size by Application (2019-2024) & (US$ Million)
Table 35. North America Personalized Cancer Medicine Market Size by Application (2025-2030) & (US$ Million)
Table 36. North America Personalized Cancer Medicine Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. North America Personalized Cancer Medicine Market Size by Country (2019-2024) & (US$ Million)
Table 38. North America Personalized Cancer Medicine Market Size by Country (2025-2030) & (US$ Million)
Table 39. Europe Personalized Cancer Medicine Market Size by Type (2019-2024) & (US$ Million)
Table 40. Europe Personalized Cancer Medicine Market Size by Type (2025-2030) & (US$ Million)
Table 41. Europe Personalized Cancer Medicine Market Size by Application (2019-2024) & (US$ Million)
Table 42. Europe Personalized Cancer Medicine Market Size by Application (2025-2030) & (US$ Million)
Table 43. Europe Personalized Cancer Medicine Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Europe Personalized Cancer Medicine Market Size by Country (2019-2024) & (US$ Million)
Table 45. Europe Personalized Cancer Medicine Market Size by Country (2025-2030) & (US$ Million)
Table 46. China Personalized Cancer Medicine Market Size by Type (2019-2024) & (US$ Million)
Table 47. China Personalized Cancer Medicine Market Size by Type (2025-2030) & (US$ Million)
Table 48. China Personalized Cancer Medicine Market Size by Application (2019-2024) & (US$ Million)
Table 49. China Personalized Cancer Medicine Market Size by Application (2025-2030) & (US$ Million)
Table 50. Asia Personalized Cancer Medicine Market Size by Type (2019-2024) & (US$ Million)
Table 51. Asia Personalized Cancer Medicine Market Size by Type (2025-2030) & (US$ Million)
Table 52. Asia Personalized Cancer Medicine Market Size by Application (2019-2024) & (US$ Million)
Table 53. Asia Personalized Cancer Medicine Market Size by Application (2025-2030) & (US$ Million)
Table 54. Asia Personalized Cancer Medicine Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 55. Asia Personalized Cancer Medicine Market Size by Region (2019-2024) & (US$ Million)
Table 56. Asia Personalized Cancer Medicine Market Size by Region (2025-2030) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Personalized Cancer Medicine Market Size by Type (2019-2024) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Personalized Cancer Medicine Market Size by Type (2025-2030) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Personalized Cancer Medicine Market Size by Application (2019-2024) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Personalized Cancer Medicine Market Size by Application (2025-2030) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Personalized Cancer Medicine Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 62. Middle East, Africa, and Latin America Personalized Cancer Medicine Market Size by Country (2019-2024) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Personalized Cancer Medicine Market Size by Country (2025-2030) & (US$ Million)
Table 64. Abbott Company Details
Table 65. Abbott Business Overview
Table 66. Abbott Personalized Cancer Medicine Product
Table 67. Abbott Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)
Table 68. Abbott Recent Developments
Table 69. Merck Company Details
Table 70. Merck Business Overview
Table 71. Merck Personalized Cancer Medicine Product
Table 72. Merck Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)
Table 73. Merck Recent Developments
Table 74. Novartis Company Details
Table 75. Novartis Business Overview
Table 76. Novartis Personalized Cancer Medicine Product
Table 77. Novartis Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)
Table 78. Novartis Recent Developments
Table 79. Amgen Company Details
Table 80. Amgen Business Overview
Table 81. Amgen Personalized Cancer Medicine Product
Table 82. Amgen Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)
Table 83. Amgen Recent Developments
Table 84. Celgene Company Details
Table 85. Celgene Business Overview
Table 86. Celgene Personalized Cancer Medicine Product
Table 87. Celgene Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)
Table 88. Celgene Recent Developments
Table 89. Bayer Company Details
Table 90. Bayer Business Overview
Table 91. Bayer Personalized Cancer Medicine Product
Table 92. Bayer Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)
Table 93. Bayer Recent Developments
Table 94. Roche Company Details
Table 95. Roche Business Overview
Table 96. Roche Personalized Cancer Medicine Product
Table 97. Roche Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)
Table 98. Roche Recent Developments
Table 99. Astellas Company Details
Table 100. Astellas Business Overview
Table 101. Astellas Personalized Cancer Medicine Product
Table 102. Astellas Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)
Table 103. Astellas Recent Developments
Table 104. Astrazeneca Company Details
Table 105. Astrazeneca Business Overview
Table 106. Astrazeneca Personalized Cancer Medicine Product
Table 107. Astrazeneca Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)
Table 108. Astrazeneca Recent Developments
Table 109. Johnson & Johnson Company Details
Table 110. Johnson & Johnson Business Overview
Table 111. Johnson & Johnson Personalized Cancer Medicine Product
Table 112. Johnson & Johnson Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)
Table 113. Johnson & Johnson Recent Developments
Table 114. Agilent Company Details
Table 115. Agilent Business Overview
Table 116. Agilent Personalized Cancer Medicine Product
Table 117. Agilent Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)
Table 118. Agilent Recent Developments
Table 119. Takeda Company Details
Table 120. Takeda Business Overview
Table 121. Takeda Personalized Cancer Medicine Product
Table 122. Takeda Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)
Table 123. Takeda Recent Developments
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Personalized Cancer Medicine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global Personalized Cancer Medicine Market Share by Type: 2023 VS 2030
Figure 3. Monoclonal Antibodies Features
Figure 4. Personalized Cancer Vaccines Features
Figure 5. Other Features
Figure 6. Global Personalized Cancer Medicine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 7. Global Personalized Cancer Medicine Market Share by Application: 2023 VS 2030
Figure 8. Breast Cancer Case Studies
Figure 9. Lung Cancer Case Studies
Figure 10. Chronic Myeloid Leukaemia Case Studies
Figure 11. Bowel Cancer Case Studies
Figure 12. Other Cancer Case Studies
Figure 13. Personalized Cancer Medicine Report Years Considered
Figure 14. Global Personalized Cancer Medicine Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Personalized Cancer Medicine Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Personalized Cancer Medicine Market Share by Region: 2023 VS 2030
Figure 17. Global Personalized Cancer Medicine Market Share by Players in 2023
Figure 18. Global Top Personalized Cancer Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Cancer Medicine as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Personalized Cancer Medicine Revenue in 2023
Figure 20. North America Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Personalized Cancer Medicine Market Share by Type (2019-2030)
Figure 22. North America Personalized Cancer Medicine Market Share by Application (2019-2030)
Figure 23. North America Personalized Cancer Medicine Market Share by Country (2019-2030)
Figure 24. United States Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Canada Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Personalized Cancer Medicine Market Size YoY (2019-2030) & (US$ Million)
Figure 27. Europe Personalized Cancer Medicine Market Share by Type (2019-2030)
Figure 28. Europe Personalized Cancer Medicine Market Share by Application (2019-2030)
Figure 29. Europe Personalized Cancer Medicine Market Share by Country (2019-2030)
Figure 30. Germany Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. France Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. U.K. Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Italy Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Russia Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Nordic Countries Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. China Personalized Cancer Medicine Market Size YoY (2019-2030) & (US$ Million)
Figure 37. China Personalized Cancer Medicine Market Share by Type (2019-2030)
Figure 38. China Personalized Cancer Medicine Market Share by Application (2019-2030)
Figure 39. Asia Personalized Cancer Medicine Market Size YoY (2019-2030) & (US$ Million)
Figure 40. Asia Personalized Cancer Medicine Market Share by Type (2019-2030)
Figure 41. Asia Personalized Cancer Medicine Market Share by Application (2019-2030)
Figure 42. Asia Personalized Cancer Medicine Market Share by Region (2019-2030)
Figure 43. Japan Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. South Korea Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. China Taiwan Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Southeast Asia Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. India Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Australia Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Personalized Cancer Medicine Market Size YoY (2019-2030) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America Personalized Cancer Medicine Market Share by Type (2019-2030)
Figure 51. Middle East, Africa, and Latin America Personalized Cancer Medicine Market Share by Application (2019-2030)
Figure 52. Middle East, Africa, and Latin America Personalized Cancer Medicine Market Share by Country (2019-2030)
Figure 53. Brazil Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 54. Mexico Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 55. Turkey Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 56. Saudi Arabia Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 57. Israel Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 58. GCC Countries Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 59. Abbott Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)
Figure 60. Merck Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)
Figure 61. Novartis Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)
Figure 62. Amgen Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)
Figure 63. Celgene Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)
Figure 64. Bayer Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)
Figure 65. Roche Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)
Figure 66. Astellas Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)
Figure 67. Astrazeneca Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)
Figure 68. Johnson & Johnson Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)
Figure 69. Agilent Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)
Figure 70. Takeda Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
Table 1. Global Personalized Cancer Medicine Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Key Players of Monoclonal Antibodies
Table 3. Key Players of Personalized Cancer Vaccines
Table 4. Key Players of Other
Table 5. Global Personalized Cancer Medicine Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 6. Global Personalized Cancer Medicine Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Personalized Cancer Medicine Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Personalized Cancer Medicine Market Share by Region (2019-2024)
Table 9. Global Personalized Cancer Medicine Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Personalized Cancer Medicine Market Share by Region (2025-2030)
Table 11. Personalized Cancer Medicine Market Trends
Table 12. Personalized Cancer Medicine Market Drivers
Table 13. Personalized Cancer Medicine Market Challenges
Table 14. Personalized Cancer Medicine Market Restraints
Table 15. Global Personalized Cancer Medicine Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Personalized Cancer Medicine Revenue Share by Players (2019-2024)
Table 17. Global Top Personalized Cancer Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Cancer Medicine as of 2023)
Table 18. Global Personalized Cancer Medicine Industry Ranking 2022 VS 2023 VS 2024
Table 19. Global 5 Largest Players Market Share by Personalized Cancer Medicine Revenue (CR5 and HHI) & (2019-2024)
Table 20. Global Key Players of Personalized Cancer Medicine, Headquarters and Area Served
Table 21. Global Key Players of Personalized Cancer Medicine, Product and Application
Table 22. Global Key Players of Personalized Cancer Medicine, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Personalized Cancer Medicine Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Personalized Cancer Medicine Revenue Market Share by Type (2019-2024)
Table 26. Global Personalized Cancer Medicine Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Personalized Cancer Medicine Revenue Market Share by Type (2025-2030)
Table 28. Global Personalized Cancer Medicine Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Personalized Cancer Medicine Revenue Share by Application (2019-2024)
Table 30. Global Personalized Cancer Medicine Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Personalized Cancer Medicine Revenue Share by Application (2025-2030)
Table 32. North America Personalized Cancer Medicine Market Size by Type (2019-2024) & (US$ Million)
Table 33. North America Personalized Cancer Medicine Market Size by Type (2025-2030) & (US$ Million)
Table 34. North America Personalized Cancer Medicine Market Size by Application (2019-2024) & (US$ Million)
Table 35. North America Personalized Cancer Medicine Market Size by Application (2025-2030) & (US$ Million)
Table 36. North America Personalized Cancer Medicine Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. North America Personalized Cancer Medicine Market Size by Country (2019-2024) & (US$ Million)
Table 38. North America Personalized Cancer Medicine Market Size by Country (2025-2030) & (US$ Million)
Table 39. Europe Personalized Cancer Medicine Market Size by Type (2019-2024) & (US$ Million)
Table 40. Europe Personalized Cancer Medicine Market Size by Type (2025-2030) & (US$ Million)
Table 41. Europe Personalized Cancer Medicine Market Size by Application (2019-2024) & (US$ Million)
Table 42. Europe Personalized Cancer Medicine Market Size by Application (2025-2030) & (US$ Million)
Table 43. Europe Personalized Cancer Medicine Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Europe Personalized Cancer Medicine Market Size by Country (2019-2024) & (US$ Million)
Table 45. Europe Personalized Cancer Medicine Market Size by Country (2025-2030) & (US$ Million)
Table 46. China Personalized Cancer Medicine Market Size by Type (2019-2024) & (US$ Million)
Table 47. China Personalized Cancer Medicine Market Size by Type (2025-2030) & (US$ Million)
Table 48. China Personalized Cancer Medicine Market Size by Application (2019-2024) & (US$ Million)
Table 49. China Personalized Cancer Medicine Market Size by Application (2025-2030) & (US$ Million)
Table 50. Asia Personalized Cancer Medicine Market Size by Type (2019-2024) & (US$ Million)
Table 51. Asia Personalized Cancer Medicine Market Size by Type (2025-2030) & (US$ Million)
Table 52. Asia Personalized Cancer Medicine Market Size by Application (2019-2024) & (US$ Million)
Table 53. Asia Personalized Cancer Medicine Market Size by Application (2025-2030) & (US$ Million)
Table 54. Asia Personalized Cancer Medicine Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 55. Asia Personalized Cancer Medicine Market Size by Region (2019-2024) & (US$ Million)
Table 56. Asia Personalized Cancer Medicine Market Size by Region (2025-2030) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Personalized Cancer Medicine Market Size by Type (2019-2024) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Personalized Cancer Medicine Market Size by Type (2025-2030) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Personalized Cancer Medicine Market Size by Application (2019-2024) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Personalized Cancer Medicine Market Size by Application (2025-2030) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Personalized Cancer Medicine Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 62. Middle East, Africa, and Latin America Personalized Cancer Medicine Market Size by Country (2019-2024) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Personalized Cancer Medicine Market Size by Country (2025-2030) & (US$ Million)
Table 64. Abbott Company Details
Table 65. Abbott Business Overview
Table 66. Abbott Personalized Cancer Medicine Product
Table 67. Abbott Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)
Table 68. Abbott Recent Developments
Table 69. Merck Company Details
Table 70. Merck Business Overview
Table 71. Merck Personalized Cancer Medicine Product
Table 72. Merck Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)
Table 73. Merck Recent Developments
Table 74. Novartis Company Details
Table 75. Novartis Business Overview
Table 76. Novartis Personalized Cancer Medicine Product
Table 77. Novartis Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)
Table 78. Novartis Recent Developments
Table 79. Amgen Company Details
Table 80. Amgen Business Overview
Table 81. Amgen Personalized Cancer Medicine Product
Table 82. Amgen Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)
Table 83. Amgen Recent Developments
Table 84. Celgene Company Details
Table 85. Celgene Business Overview
Table 86. Celgene Personalized Cancer Medicine Product
Table 87. Celgene Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)
Table 88. Celgene Recent Developments
Table 89. Bayer Company Details
Table 90. Bayer Business Overview
Table 91. Bayer Personalized Cancer Medicine Product
Table 92. Bayer Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)
Table 93. Bayer Recent Developments
Table 94. Roche Company Details
Table 95. Roche Business Overview
Table 96. Roche Personalized Cancer Medicine Product
Table 97. Roche Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)
Table 98. Roche Recent Developments
Table 99. Astellas Company Details
Table 100. Astellas Business Overview
Table 101. Astellas Personalized Cancer Medicine Product
Table 102. Astellas Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)
Table 103. Astellas Recent Developments
Table 104. Astrazeneca Company Details
Table 105. Astrazeneca Business Overview
Table 106. Astrazeneca Personalized Cancer Medicine Product
Table 107. Astrazeneca Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)
Table 108. Astrazeneca Recent Developments
Table 109. Johnson & Johnson Company Details
Table 110. Johnson & Johnson Business Overview
Table 111. Johnson & Johnson Personalized Cancer Medicine Product
Table 112. Johnson & Johnson Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)
Table 113. Johnson & Johnson Recent Developments
Table 114. Agilent Company Details
Table 115. Agilent Business Overview
Table 116. Agilent Personalized Cancer Medicine Product
Table 117. Agilent Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)
Table 118. Agilent Recent Developments
Table 119. Takeda Company Details
Table 120. Takeda Business Overview
Table 121. Takeda Personalized Cancer Medicine Product
Table 122. Takeda Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)
Table 123. Takeda Recent Developments
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Personalized Cancer Medicine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global Personalized Cancer Medicine Market Share by Type: 2023 VS 2030
Figure 3. Monoclonal Antibodies Features
Figure 4. Personalized Cancer Vaccines Features
Figure 5. Other Features
Figure 6. Global Personalized Cancer Medicine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 7. Global Personalized Cancer Medicine Market Share by Application: 2023 VS 2030
Figure 8. Breast Cancer Case Studies
Figure 9. Lung Cancer Case Studies
Figure 10. Chronic Myeloid Leukaemia Case Studies
Figure 11. Bowel Cancer Case Studies
Figure 12. Other Cancer Case Studies
Figure 13. Personalized Cancer Medicine Report Years Considered
Figure 14. Global Personalized Cancer Medicine Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Personalized Cancer Medicine Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Personalized Cancer Medicine Market Share by Region: 2023 VS 2030
Figure 17. Global Personalized Cancer Medicine Market Share by Players in 2023
Figure 18. Global Top Personalized Cancer Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Cancer Medicine as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Personalized Cancer Medicine Revenue in 2023
Figure 20. North America Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Personalized Cancer Medicine Market Share by Type (2019-2030)
Figure 22. North America Personalized Cancer Medicine Market Share by Application (2019-2030)
Figure 23. North America Personalized Cancer Medicine Market Share by Country (2019-2030)
Figure 24. United States Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Canada Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Personalized Cancer Medicine Market Size YoY (2019-2030) & (US$ Million)
Figure 27. Europe Personalized Cancer Medicine Market Share by Type (2019-2030)
Figure 28. Europe Personalized Cancer Medicine Market Share by Application (2019-2030)
Figure 29. Europe Personalized Cancer Medicine Market Share by Country (2019-2030)
Figure 30. Germany Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. France Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. U.K. Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Italy Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Russia Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Nordic Countries Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. China Personalized Cancer Medicine Market Size YoY (2019-2030) & (US$ Million)
Figure 37. China Personalized Cancer Medicine Market Share by Type (2019-2030)
Figure 38. China Personalized Cancer Medicine Market Share by Application (2019-2030)
Figure 39. Asia Personalized Cancer Medicine Market Size YoY (2019-2030) & (US$ Million)
Figure 40. Asia Personalized Cancer Medicine Market Share by Type (2019-2030)
Figure 41. Asia Personalized Cancer Medicine Market Share by Application (2019-2030)
Figure 42. Asia Personalized Cancer Medicine Market Share by Region (2019-2030)
Figure 43. Japan Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. South Korea Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. China Taiwan Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Southeast Asia Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. India Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Australia Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Personalized Cancer Medicine Market Size YoY (2019-2030) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America Personalized Cancer Medicine Market Share by Type (2019-2030)
Figure 51. Middle East, Africa, and Latin America Personalized Cancer Medicine Market Share by Application (2019-2030)
Figure 52. Middle East, Africa, and Latin America Personalized Cancer Medicine Market Share by Country (2019-2030)
Figure 53. Brazil Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 54. Mexico Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 55. Turkey Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 56. Saudi Arabia Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 57. Israel Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 58. GCC Countries Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 59. Abbott Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)
Figure 60. Merck Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)
Figure 61. Novartis Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)
Figure 62. Amgen Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)
Figure 63. Celgene Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)
Figure 64. Bayer Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)
Figure 65. Roche Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)
Figure 66. Astellas Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)
Figure 67. Astrazeneca Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)
Figure 68. Johnson & Johnson Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)
Figure 69. Agilent Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)
Figure 70. Takeda Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Circuit Simulator Market Research Report 2025
Mar 11, 25
Global Schematic Editor Market Research Report 2025
Mar 11, 25
Global Milk Green Tea Market Research Report 2025
Mar 11, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232